Mallinckrodt plc
OTC: MNKKQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mark Christopher Trudeau
- Employees
- 2,778
- Headquarters
- Dublin, Ireland
- IPO year
- 2013
- Website
- https://www.mallinckrodt.com
Loading MNKKQ…
Loading profile data…Frequently asked questions about MNKKQ
What does Mallinckrodt plc (MNKKQ) do?
Headquartered in Dublin, Ireland, Mallinckrodt plc is engaged in the global development, manufacturing, commercialization, and distribution of specialized pharmaceutical products and therapeutic solutions. The company operates through two primary divisions: Specialty Brands and Specialty Generics. Its Specialty Brands division focuses on proprie...
Where does MNKKQ trade?
Mallinckrodt plc (MNKKQ) trades on the Other OTC.
What sector is MNKKQ in?
Mallinckrodt plc (MNKKQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Mallinckrodt plc?
Mark Christopher Trudeau is the chief executive officer of Mallinckrodt plc (MNKKQ).
Where is Mallinckrodt plc headquartered?
Mallinckrodt plc is headquartered in Ireland.
Does MNKKQ pay a dividend?
Mallinckrodt plc (MNKKQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MNKKQ go public?
Mallinckrodt plc (MNKKQ) completed its initial public offering in 2013.